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emodelling of the plasma membrane cytoarchitecture
is crucial for the regulation of epithelial cell adhesion
and permeability. In Madin-Darby canine kidney
 
cells, the protein AHNAK relocates from the cytosol to
the cytosolic surface of the plasma membrane during the
formation of cell–cell contacts and the development of
epithelial polarity. This targeting is reversible and regulated
 
by Ca
 
2
 
 
 
-dependent cell–cell adhesion. At the plasma
membrane, AHNAK associates as a multimeric complex with
actin and the annexin 2/S100A10 complex. The S100A10
subunit serves to mediate the interaction between annexin 2
R
 
and the COOH-terminal regulatory domain of AHNAK.
Down-regulation of both annexin 2 and S100A10 using
an annexin 2–speciﬁc small interfering RNA inhibits the
association of AHNAK with plasma membrane. In Madin-
Darby canine kidney cells, down-regulation of AHNAK using
AHNAK-speciﬁc small interfering RNA prevents cortical
actin cytoskeleton reorganization required to support cell
height. We propose that the interaction of AHNAK with the
annexin 2/S100A10 regulates cortical actin cytoskeleton
organization and cell membrane cytoarchitecture.
 
Introduction
 
AHNAK was first identified as a gene whose transcription is
 
repressed in cell lines of neuroblastoma and some other
tumors (Shtivelman et al., 1992). More recently, transcription
of AHNAK was found to be subject to strong down-regulation
by transforming Ras alleles in rodent fibroblasts (Zuber et
al., 2000). AHNAK is a protein of an exceptionally large size
(700 kD) that is encoded by an intronless gene located on
human chromosome 11q12–13 (Shtivelman and Bishop,
1993; Kudoh et al., 1995). The deduced amino acid sequence
of human AHNAK predicts a protein of 5,643 amino acids
that can be divided into three main structural regions: the
NH
 
2
 
-terminal 251 amino acids, a large central region of
4,390 amino acids composed of the 128-aa unit repeated 26
times, and the COOH-terminal 1,002 amino acids. The
recurrent 7-aa motif present within the AHNAK repeats,
P-[ED]-[AVIL]-[ED]-L-[KR]-G, has striking similarities
with repeated domains found in two other repeat-containing
proteins, the giant sea urchin vesicle-associated protein (600
kD; Barton et al., 1992) and L-periaxin (147 kD; Dytrych et
al., 1998). Several putative regulatory elements are clustered
within the COOH terminus, including several NLSs (Nie et
al., 2000), a leucine zipper (Shtivelman and Bishop, 1993),
and several potential phosphorylation sites for PKB, PKC,
and CKII (Sussman et al., 2001). The exact biological function
of AHNAK is unknown, although several putative interact-
ing proteins have been identified. In vitro, AHNAK fragments
bind and activate PLC
 
 
 
 in the presence of arachidonic acid
(Sekiya et al., 1999). AHNAK is also a major target protein
for the calcium- and zinc-binding protein S100B (Gentil et
al., 2001). In cardiomyocytes, AHNAK associates with the
 
 
 
 subunit of cardiac L-type calcium channels at the plasma
membrane, and is phosphorylated by PKA in response to
adreno receptor stimulation (Haase et al., 1999). In vitro,
the COOH-terminal AHNAK region (aa 5262–5643) binds
to G-actin and cosediments with F-actin. A possible role for
AHNAK in the maintenance of the structural and functional
organization of the subsarcolemmal cytoarchitecture has
been proposed (Hohaus et al., 2002). More recently, AHNAK
immunoreactivity has been found within the lumen of specific
vesicles called “enlargosomes,” and is redistributed to the
external surface of the plasma membrane in response to large
increases in Ca
 
2
 
 
 
. Enlargosomes have been proposed to par-
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ticipate in cell membrane differentiation and repair (Bor-
gonovo et al., 2002). A nuclear localization of AHNAK has
also been reported (Shtivelman and Bishop, 1993; Sussman
et al., 2001). During early mouse embryonic development,
AHNAK is abundantly expressed in mesenchymal and epi-
thelial cells at the major sites of morphogenesis, where it is
essentially localized at the plasma membrane (Kingsley et al.,
2001; Downs et al., 2002). In adult mice, AHNAK has a re-
stricted tissue distribution. It is expressed at the plasma-
lemma of elastic tissues submitted to contracting and stretch-
ing forces and/or tissues forming in physical barriers that
define body compartments. AHNAK is expressed in all mus-
cular cells including cardiomyocytes, skeletal muscle cells,
smooth muscle cells, fibromyocytes, and myoepithelial cells
(Haase et al., 1999; Gentil et al., 2003). AHNAK is also
highly expressed at the plasma membrane of lining epithelial
cells (Hieda and Tsukita, 1989; Hashimoto et al., 1993;
Gentil et al., 2003), but is absent from epithelia with secre-
tory or absorptive functions (Gentil et al., 2003). The exact
mechanisms by which AHNAK is localized to the plasma
membranes remain to be investigated, especially because
AHNAK does not possess a transmembrane domain. In the
present work, we have developed cellular and molecular
analyses to elucidate the function of AHNAK at the plasma
membrane, and to identify proteins interacting with AH-
NAK in this cellular compartment. First, we show that at
the plasma membrane, AHNAK interacts with the annexin
2/S100A10 complex, which regulates AHNAK plasma mem-
brane localization. We also demonstrate that down-regula-
tion of AHNAK affects the cell membrane cytoarchitecture
of epithelial cells, and we propose a role of AHNAK in con-
trolling the physical and mechanical properties of cell-
peripheral membranes. Our results provide significant in-
sights into the molecular mechanisms by which annexin 2
regulates cell membrane organization (Babiychuk et al., 2002;
Gerke and Moss, 2002).
 
Results
 
AHNAK is redistributed at the cytosolic surface of 
the plasma membrane in confluent MDCK cells
 
In canine epithelial MDCK cells, AHNAK redistributes
from the cytoplasm to a cortical/plasma membrane localiza-
tion as cell density increases and as cells establish cell–cell
contacts (Sussman et al., 2001; Fig. 1 A). This redistribution
of AHNAK follows the reorganization of the actin cytoskele-
ton into cortical actin (Fig. 1 A). Three different AHNAK
antibodies, the affinity-purified AHNAK-KIS pAb directed
against the repeated central domain of AHNAK, the af-
finity-purified AHNAK-CQL pAb directed against the ex-
treme COOH terminus (Gentil et al., 2003), and the anti-
AHNAK (desmoyokin) antibody (DY) (Hashimoto et al., 1993)
gave a similar immunostaining pattern. A recent work has
shown that in secretory cell models, AHNAK can be local-
ized within the lumen of specific vesicles called enlargo-
somes and is redistributed to the external surface of the
plasma membrane in response to large increases in Ca
 
2
 
 
 
(Borgonovo et al., 2002). Therefore, we evaluated in conflu-
ent MDCK cells on which side of the plasma membrane
AHNAK is distributed, and whether AHNAK is present in
the lumen of cortical vesicles or in the cytoplasm. To resolve
this issue, we compared the immunostaining obtained with
our affinity-purified anti-AHNAK-KIS antibody in deter-
gent-permeabilized cells, in streptolysin O–permeabilized
cells, and in nonpermeabilized live confluent MDCK cells.
In nonpermeabilized cells, no surface AHNAK immunola-
beling was detected (unpublished data). When the plasma
membrane of live cells was permeabilized with streptolysin
O, a condition in which only cytoplasmic and not the vesicle
luminal proteins are accessible to the antibodies, the plasma
membrane was labeled (Fig. 1 B). An identical result was ob-
tained with the anti-AHNAK (desmoyokin) antibody (DY)
previously shown to recognize the membrane-bound protein
in epithelial cells (Hashimoto et al., 1993, 1995; unpub-
lished data). Even though we cannot exclude the possibility
that a population of AHNAK is present in enlargosomes,
Figure 1. Density-dependent localization of AHNAK to the cyto-
plasmic face of the MDCK cell plasma membrane. (A) Redistribution 
of AHNAK and actin during confluence mediated cell–cell contact 
and polarization. MDCK cells were cultured on glass coverslips for 
2 (a and b), 24 (c and d) or 96 h (e and f), and stained with anti-
AHNAK-KIS antibody (a, c, and e) and F-actin visualized with 
phalloidin (b, d, and f). (B) Confocal immunofluorescence with poly-
clonal anti-AHNAK-KIS antibody of streptolysin O–permeabilized 
confluent MDCK cells reveals a positive signal at the cytoplasmic 
surface of the plasma membrane. 
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these results clearly indicate that in our epithelial cell model,
AHNAK is predominantly a cytosolic protein localized at
the intracellular face of plasma membrane.
 
Membrane-bound AHNAK interacts with the annexin 
2/S100A10 complex
 
To gain further insight into AHNAK function at the plasma
membrane, we sought to identify proteins interacting with
AHNAK using coimmunoprecipitation coupled to mass
spectrometry analysis. For convenient peptide sequence
identification using human databases, we used human epi-
thelial MCF-7 cells, which predominantly express AHNAK
at the plasma membrane. Confluent MCF-7 cells were
treated with the membrane-permeable cross-linker dithiobis
succinimidyl propionate, and AHNAK was immunoprecipi-
tated with anti-AHNAK-CQL antibodies. Proteins present
within the AHNAK immunoprecipitate were reduced, sepa-
rated by SDS-PAGE, and identified by mass spectrometry.
One major protein recovered within AHNAK immunopre-
cipitate was identified as annexin 2 (Fig. S1, available at
http://www.jcb.org/cgi/content/full/jcb.200307098/DC1).
The interaction between AHNAK and annexin 2 was con-
firmed both by coimmunoprecipitation in absence of cross-
linking with two independent antibodies directed against
AHNAK and immunodetection, and by a pull-down ap-
proach using recombinant AHNAK fragments linked to the
GST tag (Fig. 2 A). The COOH-terminal fragment of AH-
NAK (Cter; aa 4642–5643), but neither a central fragment
of AHNAK (M1; aa 820–1330) nor the GST tag alone, in-
teracted with annexin 2. The interaction of annexin 2 with
AHNAK is specific because other annexin family members,
annexin IV and annexin VI, are not recovered in the AH-
NAK immunoprecipitates or in the pull-down experiments.
At the plasma membrane, annexin 2 can form a tetrameric
complex with the S100A10 subunit (Harder and Gerke,
1993), a protein that belongs to the S100 family of EF
hand–type Ca
 
2
 
 
 
-binding proteins (Schafer and Heizmann,
1996). In contrast to other S100 proteins, S100A10 has lost
the ability to bind Ca
 
2
 
 
 
 (Gerke and Weber, 1985). There-
fore, we examined whether S100A10 associates with annexin
2 when complexed to AHNAK. In both MCF-7 and
MDCK cells, S100A10 is recovered together with annexin 2
in AHNAK immunoprecipitates (Fig. 2 B). The interaction
of the annexin 2/S100A10 complex with AHNAK-Cter do-
main was confirmed in pull-down assays (Fig. 2 C). In
MDCK cells metabolically labeled with [
 
35
 
S]methionine/
cysteine, two major proteins migrating with a molecular
mass corresponding to annexin 2 and S100A10 bound spe-
cifically to the AHNAK-Cter domain (Fig. 2 C, left). The
identity of these bands as annexin 2 and S100A10 was con-
firmed by Western blot analysis (Fig. 2 C, right). The inter-
action occurred in EDTA/EGTA-containing buffer, indi-
cating that the interaction between AHNAK and annexin
2/S100A10 is Ca
 
2
 
 
 
 independent.
To evaluate the contribution of S100A10 in the annexin
2/S100A10/AHNAK interaction, we examined the effect of
the S100B protein on that interaction. Previously, we have
shown that S100B, another member of the S100 family, in-
teracts with AHNAK-Cter in a strict calcium-dependent
manner (Gentil et al., 2001). Because striking structural
similarities exist between S100A10 and Ca
 
2
 
 
 
-bound S100B
(McClintock et al., 2002), we examined whether S100B can
displace annexin 2/S100A10. First, we controlled that the
interaction between the annexin 2/S100A10 complex and
GST-AHNAK-Cter occurs in the presence of Ca
 
2
 
 
 
. Next,
we observed that in the presence of Ca
 
2
 
 
 
, but not in EGTA
(unpublished data), addition of recombinant S100B to the
cell extracts fully antagonizes the binding of the annexin
2/S100A10 complex in a dose-dependent and competitive
manner (Fig. 2 D). These data suggest that the annexin
2/S100A10- and S100B-binding domains on AHNAK-Cter
overlap, and that S100A10 mediates the interaction between
AHNAK and annexin 2.
The direct interaction of S100A10 with AHNAK was
confirmed in vitro. When expressed in rabbit reticulocyte,
S100A10 protein binds to and is pulled down by the recom-
binant GST-COOH-terminal domain of AHNAK (Fig. 2
E). No binding of rabbit reticulocyte that expressed annexin
2 could be detected (unpublished data). The direct interac-
tion of S100A10 with AHNAK was also confirmed in yeast
two-hybrid experiments. A human heart cDNA library was
screened using the extreme COOH-terminal domain of
AHNAK (CterC; aa 5124–5643) as a bait. 15 colonies were
obtained out of 2 
 
 
 
 10
 
6
 
 primary yeast transformants. The
interaction specificity was retested after the mating assays on
YC-UWLH medium and X-gal filter tests. Out of the 15 li-
brary plasmids retested, only two interacted specifically with
CterC. The remaining plasmids gave a positive result with
lamin and were considered as false positive. The nucleotide
sequence of the two positive clones revealed that they corre-
spond to S100A10. The specificity of interaction between
S100A10 and CterC is illustrated in Fig. 2 F. Only CterC is
competent for interaction with S100A10, and not CterN (aa
4642–5124), CterdLZ (aa 4642–4826), or lamin. Our dou-
ble-hybrid experiment also reveals that S100B is capable of
heterodimerizing with S100A10 in a yeast two-hybrid sys-
tem (Fig. 2 F). Heterodimerization of S100B with other
S100 proteins, such as S100A1, S100A6, and S100A11, has
been observed previously (Deloulme et al., 2000). In con-
trast to the results obtained with S100A10, no interaction
between S100B and AHNAK peptides could be detected in
the yeast two-hybrid system (unpublished data). This is
likely attributable to the limitation of yeast two-hybrid anal-
ysis to calcium-independent interactions (Deloulme et al.,
2003).
 
AHNAK and the annexin 2/S100A10 complex are 
recruited to the sites of early cell–cell contacts
 
Confocal scanning immunofluorescence analyses of conflu-
ent epithelial MDCK cells reveal that AHNAK and annexin
2 colocalize all over the plasma membrane, including the
sites of cell–cell contacts (Fig. 3 A). An identical pattern of
distribution was observed for S100A10 (unpublished data).
We had observed that AHNAK was recruited to the plasma
membrane as cell confluence increased and as cells polarized
(Fig. 1 A, e). The polarized phenotype of these cells was
confirmed by the reorganization of the actin cytoskeleton
(Fig. S2, available at http://www.jcb.org/cgi/content/full/
jcb.200307098/DC1) and the apicolateral polarization of
the tight junction marker ZO-1 (unpublished data). In po- 
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Figure 2. Interaction of the annexin 2/S100A10 complex with AHNAK. (A). MCF-7 cell extracts were incubated with glutathione-Sepharose 
(lanes 2–4) or protein A–Sepharose (lanes 5–7) in the presence of recombinant GST alone (lane 2), recombinant GST fused to AHNAK central 
repeat domain M1 (lane 3), recombinant GST fused to AHNAK COOH-terminal domain (lane 4), anti-AHNAK-CQL antibody (lane 6), or 
anti-AHNAK-KIS antibody (lane 7). Bound proteins were analyzed by Western blotting with anti-annexin 2, -4, and -6 antibodies. Lane 1 is 
total cell extract. (B). MCF-7 or MDCK cell extracts were incubated with control protein A-Sepharose beads (lanes 1and 4), or with anti-
AHNAK-CQL (lanes 2 and 6) or anti-AHNAK-KIS (lanes 3 and 5) antibodies. Coimmunoprecipitated proteins were analyzed by Western blotting 
with anti-AHNAK-KIS, anti-annexin 2, and anti-S100A10 antibodies. (C) S100A10 and annexin 2 are the major proteins that interact with the 
AHNAK Cter domain. [
35S]Methionine/cysteine labeled MDCK whole-cell extracts (total; left) were incubated with GST (lane 1) and GST 
fusion AHNAK-Cter (lane 2) in EGTA/EDTA-containing buffer. Bound proteins were resolved on SDS-PAGE and were detected either by auto-
radiography (left) or blotted on nitrocellulose membrane and detected with mixed anti-annexin 2 and anti-S100A10 mAbs (right). (D) S100B 
antagonizes annexin 2/S100A10 binding to the AHNAK Cter domain. U87 cell extracts were incubated with GST fusion AHNAK-Cter in the 
absence (lane 1) or in the presence (lanes 2 and 3) of increasing S100B concentrations in Ca
2 /Zn
2 -containing buffer. Bound proteins were 
analyzed by Western blotting using anti-annexin 2 and anti-S100A10 antibodies (left), or with anti-annexin 2 and anti-S100B antibodies 
(right). Lane 4 is total cell extract. (E) [
35S]Methionine/cysteine-labeled S100A10 was produced in rabbit reticulocyte (total), and the translation 
reaction was incubated with glutathione-Sepharose in the presence of recombinant GST (lane 1) or recombinant GST fused to the AHNAK 
COOH-terminal domain (lane 2) in Ca
2 /Zn
2 -containing buffer. Bound proteins were resolved on SDS-PAGE and detected by autoradiography. 
(F) S100A10 specifically interacts with AHNAK CterC and S100B in the yeast two-hybrid system. Top: diagram of the various AHNAK 
COOH-terminal fragments used. Yeast were cotransfected with S100A10 pACT2 vector and different baits corresponding to AHNAK Cter 
deletion mutants, S100B, and lamin cloned into the pLEX vector as indicated. The interactions were scored by the growth of transfected yeast 
on YC-UWLH medium lacking histidine (HIS) and confirmed by  -galactosidase activity assay (bgal). 
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larized epithelial cells, cell–cell contacts initiate plasma mem-
brane remodelling and the development of cell polarity
(Drubin and Nelson, 1996). Therefore, we tested the role of
the formation of cell–cell contacts in recruiting AHNAK to
the plasma membrane. Lowering the Ca
 
2
 
 
 
 concentration in the
culture medium of an MDCK monolayer interferes with the
stability of intercellular contacts (Grindstaff et al., 1998).
Treatment of confluent MDCK cells with low Ca
 
2
 
 
 
 medium
resulted in the redistribution of AHNAK and of the annexin
2/S100A10 complex from cell contacts to the cytoplasm,
and correlated with a more flattened morphology of the cells
(Fig. 3 B, a and b). This membrane dissociation of AHNAK
and of the annexin 2/S100A10 complex was reversible (Fig.
3 B, c–f). When cell–cell contacts were allowed to reform by
readdition of calcium into the culture medium, AHNAK
and the annexin 2/S100A10 complex were recruited to the
sites of cell–cell contacts with a similar kinetic of relocation
and distribution pattern. Within 30 min of calcium addi-
tion, AHNAK and S100A10 started to relocate to the newly
forming cell–cell contacts (Fig. 3 B, c and d), and to strongly
accumulate there after 3 h, as cell acquired a more cuboidal
epithelial morphology (Fig. 3 B, e and f). Coimmunopre-
cipitation experiments on cross-linked MDCK cells dur-
ing the calcium switch experiment revealed that AHNAK
forms a multimeric complex containing actin and annexin
2/S100A10, and that this association is strictly dependent on
the localization of AHNAK at the plasma membrane (Fig. 3
C, lane 4). Upon membrane dissociation of AHNAK, only
S100A10, and to a lesser extent annexin 2, are recovered
within the AHNAK immunoprecipitates (lane 2).
The interaction of the membrane-bound form of AH-
NAK with the cortical actin cytoskeleton was confirmed
by indirect immunofluorescence analysis of MDCK cells
treated with cytochalasin D, which disrupts the integrity of
the actin cytoskeleton (Fig. 3 D). As a consequence of its ef-
fect on actin, cytochalasin D treatment will also reversibly
disrupt the organization of actin-associated membrane pro-
tein. In addition to the modification in the actin pattern, cy-
tochalasin D treatment dramatically altered AHNAK distri-
bution. At the apicolateral plasma membrane, AHNAK and
actin precisely colocalized in a series of aggregates around
the cell border, supporting the association of AHNAK with
Figure 3. AHNAK colocalizes with the annexin 2/S100A10 complex at the plasma membrane in MDCK cells. (A) Confocal microscopy 
analysis (x-z axis) of the distribution in confluent MDCK cells of AHNAK (a), annexin 2 (b), and merge image (c). (B) Disruption of calcium-
dependent cell–cell contacts causes the dissociation of AHNAK and annexin 2/S100A10 from the plasma membrane. Confluent MDCK cells 
were incubated in medium containing 5 mM EGTA supplemented with 1 mM MgCl2 for 30 min at 37 C (a and b), and were then shifted to 
calcium-containing medium for 30 min (c and d) or 3 h (e and f). Cultures were double immunolabeled for AHNAK (a, c, and e) and S100A10 
(b, d, and f). Single-plane confocal microscopy (x-y axis) and x-z section (bottom) images are shown. (C) Confluent MDCK cells incubated 
with EGTA-MgCl2 medium for 30 min (lanes 1–2), then shifted back to Ca
2 -containing medium for 3 h (lanes 3 and 4), were cross-linked 
with dithiobis succinimidyl propionate. Whole-cell lysates were incubated with protein A–Sepharose beads (lanes 1 and 3) or anti-AHNAK-CQL 
antibody cross-linked onto Sepharose beads (lanes 2 and 4). Immunoprecipitated proteins were reduced and analyzed by Western blot with 
anti-AHNAK-CQL, anti-actin, mouse monoclonal anti-annexin 2, and anti-S100A10 antibodies. (D) Confocal immunofluorescence of actin 
stained with phalloidin (a) and AHNAK (b) in MDCK cells treated with 1  g/ml cytochalasin D for 1 h (c) is the merged image. 
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actin. Together, these data indicate that calcium-dependent
cell–cell adhesion provides a signal for initiating the local-
ized recruitment of AHNAK and annexin 2/S100A10 to
sites of cell–cell contacts, where they form a stable protein
complex with cortical actin cytoskeleton.
 
The annexin 2/S100A10/AHNAK complexes 
colocalize to intercellular junctions in a 
cholesterol-dependent mechanism
 
In addition to the Ca
 
2
 
 
 
-dependent association of annexin
2 with phospholipids, annexin 2 can also associate with the
plasma membrane lipid raft microdomains in a cholesterol-
dependent manner (Oliferenko et al., 1999; Babiychuk
and Draeger, 2000; Babiychuk et al., 2002). Several labo-
ratories have reported that annexin 2 may link lipid rafts
with the cortical cytoskeleton (Oliferenko et al., 1999),
and that annexin 2 recruits signaling proteins to intercellu-
lar junctions in a cholesterol-dependent manner (Hansen
et al., 2002). To test a possible association of AHNAK
with the annexin 2/S100A10 complex within lipid rafts,
we performed flotation experiments in OptiPrep™ gradi-
ents in the presence of cold Triton X-100 (Fig. 4 A). In
this gradient, the detergent-insoluble lipid rafts will float at
the interphase between the 0 and 20% OptiPrep™ layers.
In MDCK cells, a significant amount of AHNAK parti-
tioned with annexin 2 and S100A10 into the lipid raft
fraction together with caveolin-1, a known cholesterol-
binding protein (Fig. 4 A). Not all the annexin 2 cosedi-
mented with AHNAK, suggesting that only a portion of
the annexin 2/S100A10 complex interacts with AHNAK
and associates with the lipid rafts. We confirmed the asso-
ciation of AHNAK with lipid rafts in whole cells by colo-
calization of AHNAK with the FITC-labeled 
 
 
 
 subunit of
cholera toxin, which specifically binds the lipid raft gangli-
oside GM1 (Harder et al., 1998). Confocal laser scanning
microscopy of MCF-7 cells showed an extensive overlap of
AHNAK staining with the FITC-labeled cholera toxin 
 
 
 
chain at the plasma membrane, including intercellular
junctions (Fig. 4 B). Furthermore, depletion of plasma
membrane cholesterol in MDCK and MCF-7 cells with
methyl-
 
 
 
-cyclodextrin released a population of annexin 2
from the plasma membrane and totally abolished the junc-
tional membrane localization of AHNAK, causing their re-
distribution to the cell cytoplasm (Fig. 4 C).
Figure 4. AHNAK and annexin 2/S100A10 
associate with cholesterol-rich membranes. 
(A) AHNAK and annexin 2/S100A10 cofractionate 
to the lipid raft fractions. MDCK cells were lysed in 
buffer containing 1% Triton X-100 on ice, and 
flotation fractionation was performed in a 5–40% 
OptiPrep™ gradient. Fractions were analyzed by 
Western blotting using antibodies against AHNAK, 
annexin 2, and S100A10. Caveolin-1 was used as a 
marker of lipid raft–containing fraction. (B) Confocal 
microscopy analysis of FITC-cholera toxin   chain 
(a) and AHNAK (b) colocalization in MDCK cells. 
(c) Merged image. (C) Specific release of membrane-
bound AHNAK by sequestration of membrane 
cholesterol. Confocal microscopy analysis of 
AHNAK (a, b, e, and f) and annexin 2 (HH7; c, d, g, 
and h) in MCF-7 (a–d) and MDCK (e–h) cells not 
treated (a, c, e, and g) or incubated with 3.8 mM of 
methyl- -cyclodextrin (M CD) for 15 min (b and d) 
or 1 h (f and h) at 37 C before fixation. 
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Annexin 2/S100A10 down-regulation in MCF-7 cells 
interferes with membrane localization of AHNAK 
and cell height
 
To evaluate whether the annexin 2/S100A10 complex coop-
erates with AHNAK functions at the plasma membrane, we
first analyzed the incidence of annexin 2 down-regulation on
AHNAK subcellular localization. A small interfering RNA
(siRNA) duplex was designed against the human annexin 2
cDNA sequence. This siRNA does not function in down-reg-
ulating canine annexin 2 in MDCK cells, but is highly effi-
cient in human epithelial MCF-7 cells (Fig. 5 A). Transfec-
tion of MCF-7 cells with annexin 2 siRNA significantly
abrogated the expression of annexin 2, but did not affect the
levels of related annexins expressed in MCF-7, annexin 4, and
annexin 6. The down-regulation of annexin 2 in MCF-7 cells
induced a drastic concomitant down-regulation of S100A10.
This was likely the result of both transcriptional and post-
translational regulations of the S100A10 level by annexin 2, a
previously described well-known phenomenon (Puisieux et
al., 1996; Van de Graaf et al., 2003). A decrease in AHNAK
levels was also observed in transfected cells. This effect of an-
nexin 2 RNA interference on AHNAK levels was specific be-
cause the total level of actin was not affected, and the transfec-
tion with a nonspecific siRNA did not alter the levels of
AHNAK (unpublished data). Consistent with the Western
blot data, the membrane-associated AHNAK immunoreactiv-
ity dropped in annexin 2–depleted MCF-7 cells, and the re-
maining AHNAK signal appeared diffuse within the cyto-
plasm (Fig. 5 B). The interdependence that exists between the
 
expression of annexin 2/S100A10 and the recruitment of AH-
NAK at the plasma membrane was confirmed in Ca
 
2
 
 
 
 switch
experiments (Fig. 5 C). As observed with MDCK cells (Fig. 3
B), disruption of calcium-dependent cell–cell contacts causes
a reversible dissociation of AHNAK and of the annexin
2/S100A10 complex from the plasma membrane in MCF-7
cells (Fig. 5 C, a–d). However, in cells depleted with annexin
2/S100A10, AHNAK could not be re-recruited to the plasma
membrane upon Ca
 
2
 
 
 
-mediated cell–cell adhesion, and cells
retained a flattened morphology (Fig. 5 C, e and f).
Confocal microscopy analysis of actin distribution visualized
with fluorescent phalloidin in control and annexin 2/S100A10-
depleted cells confirmed the change in the morphology of cells
with low annexin 2/S100A10 content (Fig. 6 A). The overall
height of annexin 2/S100A10-depleted MCF-7 cells is de-
creased, with most of the actin-associated fluorescence found in
the more basal focal planes. Similar changes in cell morphology
and actin-associated fluorescence were also observed in MCF-7
cells depleted for AHNAK after transfection with AHNAK
siRNA (Fig. 6 B; see following paragraph). Together, these data
suggest that the membrane-associated annexin 2/S100A10
complex is essential to the recruitment of AHNAK at the
plasma membrane, and that the annexin 2/S100A10/AHNAK
complexes regulate actin-dependent cytoarchitecture.
 
AHNAK regulates the actin cytoskeleton scaffold of 
epithelial cells
 
To confirm the function of AHNAK in the regulation of
cortical actin organization, we have down-regulated AH-
Figure 5. The annexin 2/S100A10 complex mediates AHNAK targeting to the 
cell plasma membrane in MCF-7 cells. (A) Western blot analysis of MCF-7 cell 
extracts after transfection with control RNA interference (lane 1) or annexin 2 
siRNA (lane 2). Total protein extracts were probed by Western blot with anti-
annexin 2, -4 and -6 antibodies (left) or with annexin 2, AHNAK, S100A10, and 
actin antibodies (right). (B) Confocal microscopy analysis of annexin 2 (a and c) 
and AHNAK (b, d, and e) in MCF-7 cells transfected with control RNA interference 
(a and b) or annexin 2 siRNA (c–e). The cytoplasmic localization of AHNAK in 
annexin 2–depleted cells is seen in x-y (d) and x-z sections (c). (C) Down-regulation 
of annexin 2/S100A10 prevents calcium-dependent relocation of AHNAK to the 
plasma membrane. Confocal microscopy analysis of S100A10 (a, c, and e) and 
AHNAK (b, d, f) distribution in control MCF-7 cells (a–d), and in MCF-7 transfected 
with annexin 2 siRNA (e and f). MCF-7 cells were incubated in EGTA-MgCl2 
medium for 30 min (a and b), then shifted to Ca
2 -containing medium for 3 h (c–f). 
Both x-y and x-z sections are shown. 
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NAK levels in MDCK cells, which rearrange their cytoskele-
ton in a highly structured manner as they polarize concomi-
tantly with AHNAK recruitment to the plasma membrane
(Fig. 1). An siRNA designed against the highly conserved re-
peated central domains of AHNAK efficiently and specifi-
cally down-regulates AHNAK levels in MDCK cells (Fig. 7
A; Fig. S3, available at http://www.jcb.org/cgi/content/full/
jcb.200307098/DC1). We examined the effect of AHNAK
siRNA on F-actin cytoskeleton rearrangement by confocal
microscopy (Fig. 7, B–D). The extent of AHNAK down-
regulation varied among transfected cells. Cells depleted for
AHNAK were characterized by a marked disorganization of
their actin cytoskeleton, visualized with fluorescent phal-
loidin. Unlike AHNAK-expressing cells, which rearranged
their actin cytoskeleton into a lateral cortical belt and an api-
cal actin network, cells devoid of AHNAK were unable to
form an apicolateral cortical actin network, and F-actin
could only be detected in the basal confocal plane (Fig. 7
B). AHNAK-negative cells retained a flattened morphology
(Fig. 7 C). This decrease in cell height results in the void ob-
served in the higher lateral and apical focal planes (Fig. 7 B,
e and f). Note also that many AHNAK-negative cells at high
density were dislodged from the cell monolayer and acquired
rounded morphology (Fig. 7 B, arrows). This probably re-
flects an incapacity of invalidated cells to sustain density
pressure because we did not observe a loss of adhesion of
AHNAK-negative cells at low density (unpublished data).
Although down-regulation of AHNAK has a drastic effect
on actin cytoskeleton organization at the apicolateral plasma
membrane that acts to support cell height, it has only a sub-
tle effect on the basal actin organization. Cells invalidated
for AHNAK only displayed more punctuate actin stress fi-
bers on their basal side, compared with control cells (Fig. 7
D). Note also that in AHNAK-depleted cells, the annexin
2/S100A10 complex remains localized at the plasma mem-
brane (unpublished data). This observation indicates that
annexin 2/S100A10 is not sufficient to regulate actin cyto-
skeleton organization that acts to support cell height, and ar-
gues for a direct cooperation with AHNAK. Together, our
data suggest that AHNAK regulates cortical actin cytoskele-
ton organization.
 
Discussion
 
In epithelial cells, AHNAK is predominantly a cytosolic pro-
tein localized at the plasma membrane intracellular face. A
faint AHNAK immunoreactivity within the cell nuclei was
observed in cells submitted to a Ca
 
2
 
 
 
 switch (Fig. 5 C), but
was never observed in other cell culture conditions. The
apparent exclusive cytoplasmic localization of AHNAK in
MDCK cells contrasts with the results of Shtivelman’s
group, who reported nuclear localization of AHNAK in
Figure 6. Effect of the invalidation of AHNAK and annexin 2 on cell height. Confocal images of MCF-7 cells transfected either with annexin 
2 (A) or AHNAK (B) RNA interference. Apical (a and d), lateral (b and e), basal (c and f), and x-y sections and x-z merged sections (g and h) 
double immunostained for actin (A and B; d–f and h) and S100A10 (A; a–c and g) or AHNAK (B; a–c and g) reveals a similar collapse in cell 
height in both annexin 2– and AHNAK-invalidated cells. In A and B, x-y and x-z sections are from independent experiments. 
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sparse MDCK cell cultures (Sussman et al., 2001). Several
possible explanations could be envisioned to explain the
apparent discrepancies in subcellular AHNAK localization
in MDCK cells. Some discrepancies can arise from the
well-known heterogeneities in specific cell lines or clones in
the various laboratories. Differences in epitope accessibility
might also have to be considered. AHNAK nuclear immu-
noreactivity has only been reported with one antibody, FEN
(Shtivelman and Bishop, 1993; Sussman et al., 2001). Be-
cause a recent work has pointed out that FEN cross reacts
with a nuclear protein that is not recognized by two other
AHNAK-specific antibodies (Borgonovo et al., 2002), we
suggest that when located within the cell nuclei, AHNAK
may adopt a conformation that could only be revealed by a
specific antibody such as FEN.
In cultured epithelial cells, AHNAK targeting to the
plasma membrane is reversible and triggered by Ca
 
2
 
 
 
-depen-
dent cell adhesion. Disruption of E-cadherin–mediated cell–
cell contacts by low extracellular Ca
 
2
 
 
 
 results in the disso-
ciation of AHNAK from the plasma membrane. After
readdition of Ca
 
2
 
 
 
, AHNAK is rapidly re-recruited to the
plasma membrane at the sites of newly formed cell–cell con-
tacts. In contrast to the tight junction-associated protein ZO-1,
AHNAK immunoreactivity will progressively become more
widely distributed all over the plasma membrane (unpub-
lished data). In fully polarized MDCK cells, AHNAK immu-
noreactivity decorates the entire basal, lateral, and apical cell
membranes. Such distribution of AHNAK suggests that AH-
NAK is not a junctional protein. Down-regulation of AH-
NAK levels in MDCK cells using AHNAK-specific siRNA
prevents cortical actin cytoskeleton reorganization. These ob-
servations suggest a more general function for AHNAK in or-
ganizing cell cytoarchitecture at the plasma membrane.
To gain further insight into the molecular mechanisms
of AHNAK function at the plasma membrane, we have
searched for AHNAK partners at the plasma membrane. We
have identified the annexin 2/S100A10 complex as a major
AHNAK-binding protein in epithelial cells. Annexin 2 (also
called calpactin I heavy chain, p36) is a member of the an-
nexin family of Ca
 
2
 
 
 
- and phospholipid-binding proteins,
which has been implicated in membrane trafficking and or-
ganization (for review see Gerke and Moss, 2002). Annexin
Figure 7. AHNAK regulates actin-based cell membrane cytoarchitecture. (A) Down-regulation of AHNAK by siRNA in MDCK cells. Total 
cell lysates of cells treated with AHNAK RNA interference or control RNA interference were analyzed by Western blot for AHNAK, annexin 2, 
and actin levels. (B) Effect of AHNAK siRNA on actin organization. MDCK cells transfected with AHNAK RNA interference were stained for 
AHNAK (a–d) and F-actin (e–h) with phalloidin. Confocal x-y sections at the apical (a and e), upper lateral (b and f), lower lateral (c and g), 
and basal (d and h) levels of the cells show that cells devoid of AHNAK are unable to form an apicolateral cortical actin network, leaving a 
black void in the higher apicolateral planes. Rounded AHNAK-negative cells can be seen within the monolayer (arrows). (C) Confocal 
microscopy x-z merged sections of AHNAK (green) and actin (red) staining reveals that cells invalidated for AHNAK retains a flattened 
morphology. (D) The effect of AHNAK siRNA on basal actin stress fibers. Basal confocal microscopy section shows that cells invalidated for 
AHNAK (c and d) displayed disorganized actin stress fibers on their basal side, compared with control cells (a and b). 
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2 has been proposed to play a role in the organization of
cholesterol-rich membrane microdomains (Oliferenko et al.,
1999), the connection of lipid rafts with the under lying ac-
tin cytoskeleton (Harder et al., 1997; Gerke and Moss,
2002), and in cholesterol-mediated adherent junction for-
mations (Harder et al., 1997; Corvera et al., 2000). Within
cells, annexin 2 can occur either as a monomer or as a het-
eroterameric complex coupled with S100A10 (also called
calpactin I light chain, p11). The heterotetrameric annexin
2/S100A10 complex is the predominant form of annexin 2
present at the plasma membrane in epithelial cells (Harder
and Gerke, 1993). The interaction between AHNAK and
annexin 2/S100A10 occurs within the COOH-terminal do-
main of AHNAK. The direct interaction of S100A10 with
the extreme COOH-terminal domain of AHNAK observed
in vitro and in yeast two-hybrid experiments strongly sug-
gests that S100A10 mediates the interaction between AH-
NAK and annexin 2. The physical interaction between AH-
NAK and the annexin 2/S100A10 complex in the cell is
supported by several observations. First, a strict correlation
exists between accumulation of AHNAK and the annexin
2/S100A10 complex to the plasma membrane during both
confluence-mediated (Hansen et al., 2002; Fig. 1 A) and
Ca
 
2
 
 
 
-dependent cell–cell adhesion (Fig. 3). Second, at the
plasma membrane, AHNAK colocalizes with the annexin/
S100A10 complex, and a significant amount of proteins
associate with membrane rafts in a cholesterol-dependent
manner (Fig. 4). Third, annexin 2 depletion by siRNA pro-
motes AHNAK release to the cytoplasm (Fig. 5, B and C).
The annexin/S100A10 dependence for AHNAK membrane
localization strongly suggests that annexin 2/S100A10 con-
tributes to the recruitment and stabilization of AHNAK at
the plasma membrane. Two recent reports have pointed out
a role for S100A10 in targeting channel proteins to the
plasma membrane (Girard et al., 2002; Van de Graaf et al.,
2003). A more general function for the annexin 2/S100A10
in the routing of proteins to the plasma membrane must
now be considered.
Membrane-bound AHNAK not only interacts with an-
nexin 2/S100A10, but also is part of a complex containing
actin (Fig. 3, C and D). This observation is consistent with a
recent paper describing physical interaction between AH-
NAK and F-actin and G-actin (Hohaus et al., 2002), and
strongly suggests that AHNAK and annexin 2/S100A10 are
part of a submembranous complex that interacts physically
with the cortical actin cytoskeleton. Annexin 2/S100A10-
and AHNAK-depleted MCF-7 cells both display decreased
cell height. A similar and more drastic effect is observed in
polarized epithelial MDCK cells, which retain a mesenchy-
mal morphology upon AHNAK depletion (Fig. 7). Down-
regulation of AHNAK prevents the apicolateral actin cyto-
skeleton reorganization required to support cell height. We
propose that AHNAK and the annexin 2/S100A10 complex
are involved in the regulation of the actin cytoskeleton orga-
nization at the lateral plasma membrane, and thus could be
implicated in plasma membrane remodelling and in the es-
tablishment of specialized intercellular interaction. Such a
role for AHNAK is consistent with its specific expression in
most lining epithelium and in endothelial cells of imperme-
able brain capillaries and peripheral blood vessels, and con-
versely with its absence in the highly permeable fenestrated
endothelium of the kidney glomeruli, the hepatic sinusoid,
and the continuous capillaries of lung (Gentil et al., 2003).
In adult tissues, AHNAK is also abundantly expressed at the
plasma membrane of smooth muscle cells (Gentil et al.,
2003). In smooth muscle cells, annexin 2 is thought to func-
tion as a cross-linker of lipid rafts with the underlying actin
cytoskeleton to regulate sarcolemmal tension (Babiychuk
and Draeger, 2000; Babiychuk et al., 2002). In these cells,
AHNAK may cooperate with annexin 2 in the coordination
of cytoskeletal and membrane rearrangements—a coordina-
tion that provides structural support of the membrane to re-
spond to and control stretching forces (Babiychuk and
Draeger, 2000; Babiychuk et al., 2002). A similar role for
AHNAK has already been suggested in cardiac muscle (Ho-
haus et al., 2002). Although our paper highlights a structural
role of AHNAK, the association of AHNAK with lipid rafts
also opens the possibility that AHNAK could be implicated
in regulation of signaling pathways that are compartmen-
talized within these microdomains (Simons and Toomre,
2000; Zajchowski and Robbins, 2002).
 
Materials and methods
 
Cell culture
 
U87 glioblastomes, MCF-7, and MDCK epithelial cells were maintained in
DME (Life Technology), 10% FBS (Sigma-Aldrich), and 1% penicillin/strep-
tomycin.
For calcium switch experiments, cells were incubated for 30 min with
DME supplemented with 5 mM EGTA and 1 mM MgCl
 
2
 
 to lower extracel-
lular Ca
 
2
 
 
 
 concentration and to perturb strict Ca
 
2
 
 
 
-dependent cell–cell ad-
hesion, but to maintain Mg
 
2
 
 
 
-dependent cell–matrix adhesion. Cell–cell
contacts were allowed to reform for the indicated times by returning cells
to complete medium.
 
Reagents and antibodies
 
The pAbs directed against AHNAK, KIS, and CQL have been described
previously (Gentil et al., 2003). Anti-annexin 2 mAb HH7 was a gift from
V. Gerke (Universiy of Münster, Münster, Germany). Anti-annexin 2, anti-
annexin 2 light chain (S100A10), anti-annexin IV, anti-annexin VI, and
anti-caveolin-1 mAbs were purchased from Transduction Laboratories.
Texas red–phalloidin was purchased from Molecular Probes, Inc., and
anti-actin mAb was purchased from Sigma-Aldrich. FITC-labeled cholera
toxin B subunit and the cholesterol chelator methyl-
 
 
 
-cyclodextrin were
purchased from Sigma-Aldrich.
 
In vitro protein–protein interaction assay/GST pull-down
 
GST-AHNAK-Cter and GST-AHNAK-M1 proteins (Gentil et al., 2001) were
produced in the 
 
Escherichia coli
 
 AD494(DE3)pLYsS strain (Novagen) and
purified by glutathione-Sepharose affinity chromatography. For metabolic
labeling, cells were labeled in methionine-free MEM and 5% FCS supple-
mented with 50 
 
 
 
Ci/ml [
 
35
 
S]methionine/cysteine mix for 12 h. For binding
assays, cells were lysed at 4
 
 
 
C in TTBS buffer (40 mM Tris-HCl, pH 7.5,
150 mM NaCl, and 0.3% Triton X-100) plus protease inhibitors (leupeptin,
aprotinin, pepstatin, and AEBSF; 10 
 
 
 
g/ml each), and were centrifuged for
10 min. Cell lysates were precleared by incubation for 10 min with 50 
 
 
 
l
GST-Sepharose. 500-
 
 
 
l aliquots of precleared supernatant were supple-
mented with either 5 mM EDTA/5 mM EGTA or with 0.3 mM CaCl
 
2
 
/10 
 
 
 
M
ZnSO
 
4
 
 and mixed with 10 
 
 
 
g purified GST fusion proteins plus 30 
 
 
 
l affin-
ity GST-Sepharose beads equilibrated in the same buffers. After mixing for
15 min at 4
 
 
 
C, the beads were spun down and the supernatant was re-
moved. The beads were washed three times with 1 ml binding buffers. At
the last wash, beads were transferred to new tubes and boiled in SDS sam-
ple buffer.
 
Mass spectrometric analysis and protein identification
 
Proteins recovered within AHNAK immunoprecipitates were excised from
Coomassie blue–stained gels and washed with 50% acetonitrile. Gel
pieces were dried in a vacuum centrifuge and rehydrated in 20 
 
 
 
l of 25 
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mM NH4HCO3 containing 0.5  g trypsin (sequencing grade; Promega). Af-
ter 4 h incubation at 37 C, a 0.5- l aliquot was removed for MALDI-TOF
analysis and spotted onto the MALDI sample probe on top of a dried 0.5-
 l mixture of 4:3 saturated  -cyano-4-hydroxy-trans-cinnamic acid in ace-
tone/10 mg/ml nitrocellulose in acetone/isopropanol 1:1. Samples were
rinsed by placing a 5- l volume of 0.1% TFA on the matrix surface after
the analyte solution had dried completely. After 2 min, the liquid was
blown off by pressurized air. MALDI mass spectra of peptide mixtures
were obtained using a mass spectrometer (Bruker Biflex; Bruker-Fran-
zen  Analityk). Internal calibration was applied to each spectrum using
trypsin autodigestion peptides (MH  842.50, MH  1045.55, and MH 
2211.11). Protein identification was confirmed by tandem mass spectrom-
etry experiments as described previously (Gentil et al., 2001).
Double hybrid
For plasmid constructions, fusion proteins with LexA DNA-binding do-
main (LexADBD) were constructed in pLex10. For the pLex-AHNAK Cter
construction, BamHI–EcoRI AHNAK fragment (aa 4642–5643) from
pDY-C (Nishimoto) was subcloned into pcDNA3.1. The insert was then
excised with BamHI and XhoI digestion and cloned into BamHI–SalI
sites of pLex10. pLex-CterN was obtained by deleting AHNAK pstI–pstI
fragment from pLex-AHNAK Cter. To obtain the pLex-AHNAK-CterC
construct, pstI–pstI AHNAK fragment (aa 5124–5643) of pLex-AHNAK
Cter was subcloned into the pstI site of plex10. For the pLex-Cter-LZ
construct, the pLex-CterN plasmid was deleted by SalI–PstI digestion,
blunted with Deep vent polymerase, and self ligated. pLexS100B was
obtained by amplification of human S100B cDNA using primers con-
taining SmaI and pstI sites immediately flanking the start and the stop
codon, respectively, and cloning of the PCR product into SmaI–pstI sites
of pLex10.
Large-scale yeast transformations using the human heart Matchmaker™
cDNA library constructed in pACT2T plasmid (CLONTECH Laboratories,
Inc.) and two-hybrid screens were performed using an L40 yeast strain es-
sentially as described previously (Deloulme et al., 2000). Primary transfor-
mants were analyzed on YC-UWLH medium plates. Growing clones were
then tested for  -galactosidase expression (Deloulme et al., 2000). Library
plasmids expressing LEU2 from positive transformants were selected using
HB101 E. coli, which requires leucine supplementation for growth. cDNAs
were retested in a mating assay against the original bait construct and
pLexA-lamin as a control using the AMR70 yeast strain as described be-
low. The interactions were also tested by yeast mating essentially as de-
scribed previously (Deloulme et al., 2000).
Immunoprecipitation and Western blotting
For total cell lysates and coimmunoprecipitation, cells were washed in
PBS and lysed on ice in lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl,
0.05% deoxycholic acid, 1% Triton X-100, 10% glycerol, 2 mM EDTA/
EGTA, and protease inhibitor cocktail). Lysates were passed through a 26G
needle and centrifuged for 10 min at 2,500 rpm in a tabletop centrifuge.
Supernatants were either quantified with the BCA protein micro assay
(Pierce Chemical Co.) and boiled in 1  DTT Laemmli buffer (total cell ly-
sates), or incubated with either anti-AHNAK-KIS antibody together with
protein A–Sepharose (Amersham Biosciences), anti-AHNAK-CQL antibody
cross-linked onto Sepharose beads, or with protein A–Sepharose alone, for
1 h rotating at 4 C. The immunoprecipitates were washed three times in ly-
sis buffer, and the beads boiled in 1  Laemmli with 20 mM DTT. Proteins
were separated by SDS-PAGE using 5, 8, or 14% polyacrylamide concen-
trations to resolve AHNAK, actin, or annexin 2/S100A10, respectively.
Proteins were blotted onto nitrocellulose membranes.
For cross-linking experiments, cells were washed in PBS, incubated for
5 min with 0.5 mM dithiobis succinimidyl propionate (Pierce Chemical
Co.) in PBS, and washed twice in 50 mM glycine in PBS before cell lysis
and AHNAK immunoprecipitation. Immunoprecipitated proteins were re-
duced by boiling for 5 min in 1  Laemmli buffer containing 5%  -mer-
captoethanol, and were analyzed by Western blot.
RNA interference
21-nt siRNA duplexes targeting the 5 -AAGAUCUCCAUGCCUGAUGUG-
3  mRNA sequence in the repeated domains of ahnak, and the 5 -
AAGUGCAUAUGGGUCUGUCAA-3  mRNA sequence corresponding to
the NH2-terminal domain of human annexin 2 were purchased from Dhar-
macon. The sequence used was submitted to a BLAST search to ensure tar-
geting specificity. The specificity of AHNAK and annexin 2 down-regula-
tion was further checked by Western blotting analysis. MCF-7 or MDCK
cells plated at low density (3   10
4/cm
2) were transfected with 20 nM of
either annexin 2 or AHNAK siRNA duplex, or scrambled siRNA using Oli-
gofectamine™ (Life Technologies) on two consecutive days, and main-
tained for a total of 4 d in DME 10% serum.
Immunofluorescence
Cells were either fixed in 4% PFA for 10 min at RT, followed by a perme-
abilization with 0.1% Triton X-100 for 10 min or with 70% methanol at
 20 C for 10 min. Cells were then washed in TBS and incubated with the
primary antibody in TBS containing 3% goat serum overnight at 4 C. After
TBS washes, cells were then incubated for 1 h at RT with the secondary
antibody in TBS goat serum, and phalloidin when required. The secondary
antibodies coupled with Alexa
® 488 were purchased from Molecular
Probes, Inc., and those coupled with Cy3 and Cy5 were purchased from
Jackson ImmunoResearch Laboratories. After the final washes, cells were
mounted in fluorescence mounting medium (DakoCytomation) and ana-
lyzed with a fluorescent microscope (Axiovert 200M; Carl Zeiss MicroIm-
aging, Inc.) or a confocal microscope (TCS-SP2; Leica).
For plasma membrane permeabilization, cells were treated with 0.5 U
streptolysin O (Sigma-Aldrich) in 0.1% BSA-PBS at 4 C and transferred at
37 C for 5 min. Cells were then washed with PBS and incubated with the
primary antibody diluted in PBS/5% goat serum for 30 min at 4 C. After
PBS washes, cells were fixed with 4% PFA and processed as above.
Cholera toxin labeling of GM1
MCF-7 cells were incubated with 0.5  g/ml FITC-labeled cholera toxin  
chain in DME for 4 min at 37 C. Cells were then washed twice with DME,
fixed with 4% PFA for 10 min at RT, and permeabilized with 0.1% Triton
X-100 for 10 min at RT. Cells were then analyzed by immunofluorescence
for AHNAK and S100A10.
Flotation gradients
For the isolation of lipid rafts, cells grown in 100-mm tissue culture dishes
were washed and scraped in PBS, pelleted, and lysed on ice for 30 min in
100  l Triton X-100 lysis buffer (400 mM Tris, pH 7.5, 150 mM NaCl, 1
mM DTT, 1% Triton X-100, and protease inhibitor cocktail). After a 10-
min spin at 2,500 rpm at 4 C, the supernatant was mixed with 200  l of a
60% OptiPrep™ (Axis-Shield) solution to obtain a 40% final solution, and
transferred to centrifuge tubes. The sample was overlayed with 270  l of a
35, 30, 25, 20, and 5% solution of OptiPrep™ in Triton lysis buffer. The
gradient was centrifuged in an ultracentrifuge (Optima TL; Beckman
Coulter) at 45,000 rpm for 4 h at 4 C in a rotor (TLS-55; Beckman Coulter).
The fractions were collected and analyzed by Western blotting.
Online supplemental material
Fig. S1 shows a Coomassie blue stain of the proteins coimmunoprecipi-
tated with AHNAK. Fig. S2 shows the rearrangement of the actin cytoskel-
eton in polarized MDCK cells. Fig. S3 shows the specific down-regulation
of AHNAK protein by immunofluorescence in MDCK cells treated with
AHNAK siRNA. The online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200307098/DC1.
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